- Home
- PMN vs AEON Comparison
PMN vs AEON Comparison
Compare PMN & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- AEON
- Stock Information
- Founded
- PMN 2004
- AEON N/A
- Country
- PMN Canada
- AEON United States
- Employees
- PMN N/A
- AEON N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- PMN Health Care
- AEON Health Care
- Exchange
- PMN Nasdaq
- AEON Nasdaq
- Market Cap
- PMN 16.0M
- AEON 8.0M
- IPO Year
- PMN N/A
- AEON N/A
- Fundamental
- Price
- PMN $0.52
- AEON $0.83
- Analyst Decision
- PMN Strong Buy
- AEON Strong Buy
- Analyst Count
- PMN 3
- AEON 1
- Target Price
- PMN $4.33
- AEON $360.00
- AVG Volume (30 Days)
- PMN 4.8M
- AEON 228.8K
- Earning Date
- PMN 08-07-2025
- AEON 08-11-2025
- Dividend Yield
- PMN N/A
- AEON N/A
- EPS Growth
- PMN N/A
- AEON N/A
- EPS
- PMN N/A
- AEON 117.22
- Revenue
- PMN N/A
- AEON N/A
- Revenue This Year
- PMN N/A
- AEON N/A
- Revenue Next Year
- PMN N/A
- AEON N/A
- P/E Ratio
- PMN N/A
- AEON $0.01
- Revenue Growth
- PMN N/A
- AEON N/A
- 52 Week Low
- PMN $0.38
- AEON $0.38
- 52 Week High
- PMN $2.22
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- PMN 58.75
- AEON 56.85
- Support Level
- PMN $0.48
- AEON $0.80
- Resistance Level
- PMN $0.43
- AEON $0.87
- Average True Range (ATR)
- PMN 0.09
- AEON 0.06
- MACD
- PMN 0.00
- AEON -0.00
- Stochastic Oscillator
- PMN 16.09
- AEON 68.06
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.